A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed concerned the employment of 18-fluorine fluorodeoxyglucose positron emission tomography/computed tomography (PET-CT) in the preoperative evaluation of thymic epithelial neoplasms (TENs). We reviewed its role as a predictor of Masaoka stage and histology (according to the WHO). In clinical practice, stage is considered the most important determinant in the therapeutic approach. A total of 265 papers were found as a result of the reported search, of which 14 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. All the studies are retrospective analyses. Patient numbers varied from 13 to 58. Our research showed that PET-CT could clearly add information about the histology of the tumour. Thymic carcinoma constantly showed a higher standard uptake value (SUV max ) than thymomas. Furthermore, in one retrospective study of 36 patients, when using a derived PET indicator, the T/M ratio (ratio between SUV max of the tumour and SUV max of mediastinum, as conventionally measured at the level of the aortic arc), PET-CT could also differentiate between low-and high-risk thymomas (low risk vs high risk P = 0.01). In another study, a cut-off value of T/M ratio of 2.75 was identified between low-and high-risk TENs. The role of PET-CT in prediction of stage is harder to recognize. In one study, there was a statistically significant correlation between SUV max , T/M ratio and Masaoka stage (P = 0.781 and 0.718, respectively). When analysing the data from the three larger series on this topic (58, 51 and 47 patients, the latter group selected in a multicentre study), only one study identified a correlation between SUV max and Masaoka stage (Spearman correlation coefficient 0.30, P = 0.0436), while the other two failed to identify a relationship between SUV max and stage. In three retrospective studies, PET-CT identified otherwise undetected distant metastases, thereby modifying the clinical approach. Actually, when evaluating the correlation between stage and PET-CT indicators (in particular SUV max ), results are controversial and would need further speculation.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . 
THREE-PART QUESTION

CLINICAL SCENARIO
A 57-year old patient presented with an incidental finding of an isolated thymic mass 3 cm in diameter after a computed tomography (CT) scan of the thorax. It looked like it might be adherent to the pericardium. The patient also had a positron emission tomography (PET-CT) scan and the lesion was found to have a standard uptake value (SUV max ) of 8.3. The patient underwent minimally invasive procedure. However, due to invasion of the pericardium, conversion to sternotomy was required. Pathological evaluation confirmed a B3 thymoma with infiltration into the pericardium (Masaoka-Koga Stage III). Afterwards, you wondered whether PET-CT would be useful in the preoperative evaluation of all patients with mediastinal masses and, in particular, its role in predicting histology and stage of thymic epithelial neoplasms (TENs). You resolve to check the literature yourself. The difference between mean SUV max and T/M ratio proved to be significant between low-and Ki-67 expression turned out to be significantly higher in high-risk thymomas (P = 0.0002)
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PET/CT OR PET-CT]. All the results were screened for adherence to the topic. Case reports were excluded.
SEARCH OUTCOME
Two hundred and sixty-five papers were found as a result of the reported search. From these, 14 papers provided the best evidence to answer the question. These are presented in Table 1 .
RESULTS
Many factors have been studied in the evaluation of prognosis for TENs. Large series identified as independent prognostic factors histology and Masaoka-Koga stage [17, 18] . In clinical practice, however, stage is considered the most important determinant of the therapeutic approach. Locally advanced stages (III and IV) would benefit from preoperative, platinum-based chemotherapy. Stage is mainly predicted based on indirect radiological signs The difference of SUV max between carcinomas and the other forms was statistically significant (P = 0.000482). Differences between LR and HR not significant 6/11 (55%) carcinomas showed distant metastases PET-CT scan may indicate metastases, which are sometimes difficult to detect using other modalities (i.e. phrenic nerve palsy to indicate infiltration into the mediastinal pleura and the phrenic nerve). Okamura grouped together A, AB and B1 types as 'low-risk thymomas' (low invasiveness and better prognosis), and B2 and B3 as 'high-risk thymomas' (more aggressive) [10] . A CT scan of the thorax is ineffective in differentiating between those two groups [19] . Therefore, a more precise indication about histology and stage in the pretreatment work-up should be useful. A growing group of retrospective studies of small groups of patients evaluated the role of PET-CT in preoperative evaluation (mainly correlation with histology and staging) of TENs.
PET-CT in prediction of histology
Sung et al.
[2] identified a significant difference in SUV max between thymoma and thymic carcinomas. The author concluded that PET-CT can be employed in the preoperative work-up of thymomas, and SUV max can be a good predictor of histology and stage. SUV max turned out to be significantly higher in carcinomas in the groups studied by Kumar et al. [3] , Igai et al. [4] , Fukumoto et al. [5] , Shibata et al. [6] and more recently, Korst et al. [7] . Benveniste et al.
[8] identified a SUV max cut-off value of 6 between thymomas and carcinomas. In other studies, a significant difference in SUV max was observed also between low-and high-risk thymomas. Those studies introduced another metabolic descriptor, besides SUV max , that is the ratio between SUV max and mean SUV of the mediastinum conventionally measured at the level of the aortic arch (SUV T/M ratio). This derived descriptor could avoid some of the bias of simple SUV max such as biological factors (difference of tracer uptake among the patients) and inter-scanner variability. In a cohort of 36 patients, Endo et al. [9] identified a significant relationship between T/M ratio and histological subtype in TENs when a three-group classification was employed (low-risk, highrisk and carcinomas). Terzi et al. [11] identified in a cohort of 26 consecutive patients a strong correlation between SUV T/M ratio and risk groups. A cut-off value between the two classes was identified at an SUV T/M ratio of 2.75. Matsumoto et al. [12] and Viti et al. [13] identified a correlation between, respectively, SUV max and T/M ratio of TEN and the expression of Ki-67, a marker of proliferation and biological aggressiveness, thereby providing a correlation between biological behaviour of TENs and imaging observation. We may conclude that PET-CT may have a possible role in definition ( prediction) of histology.
PET-CT and prediction on stage
As far as correlation between PET-CT indicators and stage is concerned, the results are more ambiguous. Previously mentioned studies failed to find a correlation between SUV max and T/M ratio with stage [9, 13] . In another study [11] , there was a statistically significant correlation between SUV max , T/M ratio and disease stage (P = 0.781 and 0.718, respectively, according to Bravais-Pearson linear correlation). Matsumoto et al. [12] found a higher SUV max in Stage IV than in Stages I and II (P < 0.008 and <0.001), while the difference between Stages III and IV was not statistically significant. Consequently, the authors underline that it is impossible to specify each Masaoka stage with the absolute value of SUV max . Toba et al. [14] drew similar results in a cohort of 33 patients. Stage III and IV TENs showed higher SUV max than Stage I (P = 0.002 and 0.002). The MD Anderson experience [8] underlines the need for PET indicators other than SUV max as possible predictors of stage.
In particular, the volume of the metabolic 'avid' tumour, depicted by volume of tumour above 45 of SUV max and volume of tumour above SUV max 3.5 proved to be more related to advanced stage than SUV max (P = 0.002, 0.029 and 0.27, respectively). On the other hand, the first multicentre analysis performed on a cohort of 47 patients [15] employed another 'derived' indicator that is the ratio of tumour SUV max /tumour size (SUV max /T index). Again, SUV max /T index failed to provide information about stage, although correlating with WHO classification. However, in this study, simple SUV max related to Masaoka stage (Spearman correlation coefficient 0.30, P = 0.0436). Three studies [2, 11, 16] reported the possible usefulness of PET-CT in identifying otherwise unsuspected distant metastases, modifying the therapeutic approach. Therefore, besides the possibility of localization of otherwise unknown distant metastases, the role of PET-CT in preoperative staging is limited and needs further speculation. In particular, 'volumetric' indicators and new tracers should be evaluated.
CLINICAL BOTTOM LINE
The results, as emerged from the selected literature, are not univocal to define the role of PET-CT indicators (SUV max , T/M ratio and volumetric indicators such as tumour volume above 45% of SUV max ) as possible predictors of stage, and further studies are needed. PET-CT could be a useful tool in localizing distant metastases and in predicting histological type or risk group of TENs. The parameters employed should include SUV T/M ratio, besides standard SUV max , in order to avoid biological and technical bias.
